Sort by
Refine Your Search
-
by the EU programme Horizon Europe. The main aim of the project is to unveil the role of the Epstein-Barr virus (EBV) in the onset and progression of the Multiple Sclerosis (MS) disease. The position
-
for epidemiology and medical statistics. The position is part of the project “Targeting the Epstein-Barr virus to treat and prevent MS (EBV-MS)”, financed by the EU programme Horizon Europe. The main aim
-
at the Department). The PhD-project will be connected to the research group of Prof. Nathalie Reuter at the Department of Chemistry and the Computational Biology Unit , in collaboration with Prof. Odd André Karlsen
-
. If the successful applicant is qualified for teaching compulsory courses in the master’s program at the Faculty of Law, the position may be extended to 4 years for career promoting activities with emphasis
-
contact information for two referees. One of these should be the main advisor from the PhD programme. CV (preferably uploaded as a separate attachment, maximum 4 pages) transcripts and diplomas. If you have
-
applicant's research interests and motivation for applying for the position. the names and contact information for two referees. One of these should be the main advisor from the PhD programme. CV (preferably
-
. The position is for a fixed term of 3 years and is associated with the Computational Biology Unit (CBU, https://cbu.w.uib.no/ ), financed by University of Bergen. The position is open to an incoming candidate
-
). About the LEAD AI fellowship programme LEAD AI is the University of Bergen's career and mobility fellowship program for training 19 postdoctoral fellows in artificial intelligence. The program has
-
-based drug design. The position is for a fixed term of three years and is associated with the LEAD AI project co-funded by European Union’s Horizon Europe research and innovation programme under the Marie
-
. The position is for a fixed term of 3 years and is associated with the LEAD AI project co-funded by European Union’s Horizon Europe research and innovation programme under the Marie Skłodowska-Curie Grant